Companies: 10,795·Total market cap: $144.5T
Global Cord Blood Corporation

Global Cord Blood Corporation

CORBFOTCHealthcare● Active
$0.95
+$0.00(+0.00%)
Market Cap$127218975
P/E Ratio
52W High$1.75
52W Low$0.2
Overview
Foreign Private Issuer · Files 20-F / 6-K

Global Cord Blood Corporation (CORBF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001467808 · CORBF · OTC · as of Jun 9, 2026

Filing snapshot

395
Total Filings
6-K
Latest Form
2026-06-04
Most Recent
2007
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001467808 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2022-08-16
Fiscal Year End
Aug 16, 2022
Accession No.
0001104659-22-091776
Primary Document
co-20210331x20f.htm
Source: data.sec.gov · CIK 0001467808 · Accession 0001104659-22-091776

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-04
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-04
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-03
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-12-03
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-09-02
View
NT 20-FNT 20-F
NT 20-F
2025-08-14
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-06-03
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-05-15
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-03-04
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-02-12
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2024-12-03
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2024-09-04
View
NT 20-FNT 20-F
NT 20-F
2024-08-09
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2024-07-26
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2024-07-19
View
6-K/A6-K/A
REPORT OF FOREIGN PRIVATE ISSUER
2024-06-04
View
Showing 1–15 of 354 filingsForm 4 / 144 hidden· 395 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001467808  |  Exchange: OTC · Healthcare

Global Cord Blood Corporation (OTC: CORBF) has submitted 395 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2007. As a Healthcare sector company with CIK 0001467808, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Global Cord Blood Corporation's most comprehensive regulatory disclosure. The most recent Global Cord Blood Corporation 10-K was filed on 2022-08-16 for fiscal year ending 2022. Historical CORBF 10-K annual reports are available from 2009 through 2022.

Investors researching Global Cord Blood Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

CORBF SEC Filings · 8 questions

Global Cord Blood Corporation (CORBF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 395 filings and access original documents at no cost. Global Cord Blood Corporation's CIK is 0001467808.

CORBF SEC filingsGlobal Cord Blood Corporation SEC documentsfind CORBF 10-K